What is HawkCell?
HawkCell is an innovative company dedicated to enhancing efficiency and sustainability within the healthcare industry, specifically focusing on veterinary medicine and preclinical research. The company has developed a patented plug-and-play solution that transforms human MRI machines into dedicated animal imaging devices. This technology addresses a critical need for specialized veterinary MRI, positioning HawkCell as a key player in this niche market. Having established a strong presence in Europe, HawkCell is now poised for rapid expansion into the United States and Asia, with the ambition to become the global leader in animal MRI solutions. Their strategy includes augmented MRI offerings and strategic alliances with leading MRI manufacturers.
How much funding has HawkCell raised?
HawkCell has raised a total of $5.5M across 1 funding round:
Series A
$5.5M
Series A (2024): $5.5M with participation from MIG
Key Investors in HawkCell
MIG
MIG, headquartered in Berkeley, California, is an architecture company specializing in design and engineering in the community. Their involvement suggests a strategic interest in the infrastructure and operational aspects of HawkCell's technology deployment.
What's next for HawkCell?
With the recent major strategic investment, HawkCell is well-positioned to accelerate its ambitious growth plans. The company's focus will likely be on scaling its operations, particularly its expansion into the lucrative US and Asian markets. Further development of its augmented MRI solutions and strengthening partnerships with major MRI manufacturers will be crucial. This funding will enable HawkCell to solidify its market leadership and continue its mission to make advanced animal imaging more accessible and efficient.
See full HawkCell company page
